IDEAS home Printed from https://ideas.repec.org/a/wly/riskan/v15y1995i4p533-537.html
   My bibliography  Save this article

Tissue Dosimetry, Pharmacokinetic Modeling, and Interspecies Scaling Factors

Author

Listed:
  • Melvin E. Andersen
  • Harvey Clewell III
  • Kannan Krishnan

Abstract

Interspecies scaling factors (ISFs) are numbers used to adjust the potency factor (for example, the q1* for carcinogens or reference doses for compounds eliciting other toxic endpoints) determined in experimental animals to account for expected differences in potency between test animals and people. ISFs have been developed for both cancer and non‐cancer risk assessments in response to a common issue: toxicologists often determine adverse effects of chemicals in test animals and then they, or more commonly risk assessors and risk managers, have to draw inferences about what these observations mean for the human population. This perspective briefly reviews the development of ISFs and their applications in health risk assessments over the past 20 years, examining the impact of pharmacokinetic principles in altering current perceptions of the ISFs applied in these health risk assessments, and assessing future directions in applying both pharmacokinetic and pharmacodynamic principles for developing ISFs.

Suggested Citation

  • Melvin E. Andersen & Harvey Clewell III & Kannan Krishnan, 1995. "Tissue Dosimetry, Pharmacokinetic Modeling, and Interspecies Scaling Factors," Risk Analysis, John Wiley & Sons, vol. 15(4), pages 533-537, August.
  • Handle: RePEc:wly:riskan:v:15:y:1995:i:4:p:533-537
    DOI: 10.1111/j.1539-6924.1995.tb00346.x
    as

    Download full text from publisher

    File URL: https://doi.org/10.1111/j.1539-6924.1995.tb00346.x
    Download Restriction: no

    File URL: https://libkey.io/10.1111/j.1539-6924.1995.tb00346.x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Harvey J. Clewell & Bruce M. Jarnot, 1994. "Incorporation of Pharmacokinetics in Noncancer Risk Assessment: Example with Chloropentafluorobenzene," Risk Analysis, John Wiley & Sons, vol. 14(3), pages 265-276, June.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.

      More about this item

      Statistics

      Access and download statistics

      Corrections

      All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:riskan:v:15:y:1995:i:4:p:533-537. See general information about how to correct material in RePEc.

      If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

      If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

      If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

      For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: https://doi.org/10.1111/(ISSN)1539-6924 .

      Please note that corrections may take a couple of weeks to filter through the various RePEc services.

      IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.